Abstract:Background Neuropilin - 2 ( NRP2) is a high-affinity kinase-deficient receptor for vascular endothelial growth factor ( VEGF) and semaphorin 3F. We investigated its function in human colorectal cancers.Methods Immunohistochemistry and immunoblotting were used to assess NRP2 expression levels in colorectal tumors and colorectal cancer cell lines, respectively. HCT-116 colorectal cancer cells stably transfected with short hairpin RNA ( shRNAs) against NRP2 or control shRNAs were assayed for proliferation by the tetrazolium salt 3-( 4,5-dimethylthiazol-2-yl)- 2,5- diphenyltetrazolium bromide ( MTT) assay and for activation of the VEGFR1 pathway by immuno blotting. Soft agar assays, Annexin V staining, and Boyden chamber assays were used to examine anchorage-independent growth, apoptosis in response to hypoxia, and cell migration/ invasion, respectively, in HCT-116 transfectants. Tumor growth and metastasis were analyzed in mice ( groups of 10) injected with shRNA-expressing HCT-116 cells. The effect of in vivo targeting of NRP2 by small interfering RNA ( siRNA) on the growth of hepatic colorectal tumors derived from luciferase-expressing HCT-116 cells was assessed by measuring changes in bioluminescence and final tumor volumes. All statistical tests were two-sided.Results NRP2 expression was substantially higher in tumors than in adjacent mucosa. HCT-116 transfectants with reduced NRP2 levels had reduced VEGFR1 signaling, but proliferation was unchanged. Anchorage-independent growth, survival under hypoxic conditions, and motility/ invasiveness were also reduced. In vivo, HCT-116 transfectants with reduced NRP2 demonstrated decreased tumor growth, fewer metastases, and increased apoptosis compared with control cells. Hepatic colorectal tumors in mice treated with NRP2 siRNAs were statistically significantly smaller than those in mice treated with control siRNAs ( at 28 days after implantation, mean control siRNAs = 420 mm(3), mean NRP2 siRNAs = 36 mm(3), NRP2 vs control: difference = 385 mm(3), 95% confidence interval = 174 mm(3) to 595 mm(3), P =.005).Conclusion NRP2 on colorectal carcinoma cells is important for tumor growth and is a potential therapeutic target in human cancers where it is expressed.

Neuropilin-2 Mediates VEGF-C–induced Lymphatic Sprouting Together with VEGFR3

Neuropilin-2–Mediated Tumor Growth and Angiogenesis in Pancreatic Adenocarcinoma

Abstract #1989: Down-regulation of Neuropilin-2 Suppresses in Vivo Growth of Gastric Cancer and Sensitizes Cells to 5Fu-Induced Apoptosis

Neuropilin-2 is Involved in Tumor Growth and Angiogenesis of Pancreatic Adenocarcinoma

Abnormal Lymphatic Vessel Development in Neuropilin 2 Mutant Mice.

Neuropilin-2 Mediated Β-Catenin Signaling and Survival in Human Gastro-Intestinal Cancer Cell Lines.

Therapeutic Targeting of Neuropilin-2 on Colorectal Carcinoma Cells Implanted in the Murine Liver

Neuropilin-1 controls vascular permeability through juxtacrine regulation of endothelial adherens junctions

Distinct Vascular Endothelial Growth Factor Signals for Lymphatic Vessel Enlargement and Sprouting.

CD146 is required for VEGF-C-induced lymphatic sprouting during lymphangiogenesis

NRP1 interacts with endoglin and VEGFR2 to modulate VEGF signaling and endothelial cell sprouting

A Critical Role of VEGFR2 in Lymphatic Tumor Metastasis

Neuropilin 1 sequestration by neuropathogenic mutant glycyl-tRNA synthetase is permissive to vascular homeostasis

Vascular FLRT2 regulates venous-mediated angiogenic expansion and CNS barriergenesis

Supplementary Figure 2 from Neuropilin-2 Promotes Extravasation and Metastasis by Interacting with Endothelial Α5 Integrin

Data from Neuropilin-2 Promotes Extravasation and Metastasis by Interacting with Endothelial Α5 Integrin

Lymphangiogenesis requires Ang2/Tie/PI3K signaling for VEGFR3 cell-surface expression

Role of NRP-1 in VEGF-VEGFR2-Independent Tumorigenesis

Notch restricts lymphatic vessel sprouting induced by vascular endothelial growth factor

Supplementary Figure 5 from Neuropilin-2 Promotes Extravasation and Metastasis by Interacting with Endothelial Α5 Integrin

S1PR1 regulates the quiescence of lymphatic vessels by inhibiting laminar shear stress–dependent VEGF-C signaling